Nonprescription steroids on the internet

Substance Use and Misuse

Volumn 47, Issue 3, 2012, Pages 329-341

  Clement, Christen L ^b   Marlowe, Douglas B ^a,b   Patapis, Nicholas S ^d   Festinger, David S ^a,b   Forman, Robert F ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b TREATMENT RESEARCH INSTITUTE   (United States)

^c ALKERMES INC   (United States)

^d SPIN Inc   (United States)

Author keywords

Anabolic androgenic steroids; Internet; No prescription sales; Nonprescription Web sites; Steroid misuse; Steroids

Indexed keywords

ANABOLIC AGENT; ANDROGEN;

ADDICTION; ARTICLE; COMMERCIAL PHENOMENA; HUMAN; INTERNET; INTERPERSONAL COMMUNICATION;

ANABOLIC AGENTS; ANDROGENS; COMMERCE; COMMUNICATION; HUMANS; INTERNET; SUBSTANCE-RELATED DISORDERS;

EID: 84855500375     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826084.2011.630225     Document Type: Article

References (50)

1. Bahrke, M., Yesalis, C., Kopstein, A., & Stephens, J. (2000). Risk factors associated with anabolic-androgenic steroid use among adolescents. Sports Medicine, 29(6), 397-405. (Pubitemid 30392020)
2. Bhasin, S., Storer, T., Berman, N., Callegari, C., Clevenger, B., Phillips, J., et al. (1996). The effects of supraphysiological doses of testosterone on muscle size and strength in normal men. New England Journal of Medicine, 335, 1-6.
3. Bhasin, S., Storer, T., Berman, N., Yarasheski, K., Clevenger, B., Phillips, J., et al. (1997). Testosterone replacement increases fatfree mass and muscle size in hypogonadal men. Journal of Clinical Endocrinology and Metabolism, 82(2), 407-413. (Pubitemid 27068601)
4. Bhasin, S., Storer, T., Javanbakht, M., Berman, N., Yarasheski, K., Phillips, J., et al. (2000). Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels. Journal of the American Medical Association, 283(6), 763-770. (Pubitemid 30084616)
5. Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A., Bhasin, D., Berman, N., et al. (2001). Testosterone dose-response relationships in healthy young men. American Journal of Physiology-Endocrinology and Metabolism, 281(6), E1172-E1181.
6. Brill, K., Weltman, A., Gentili, A., Patrie, J., Fryburg, D., Hanks, J., et al. (2002). Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men. Journal of Clinical Endocrinology and Metabolism, 87, 5649-5657. (Pubitemid 36034373)
7. Brin, S., & Page, L. (1998). The anatomy of a large-scale hypertextual web search engine. Computer Networks and ISDN Systems, 30(1), 107-117.
8. Brodsky, I., Balagopal, P.,&Nair, K. (1996). Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men: A clinical research center study. Journal of Clinical Endocrinology and Metabolism, 81, 3469-3475. (Pubitemid 26339901)
9. Bross, R., Javanbakht, M., & Bhasin, S. (1999). Anabolic interventions for aging-associated sarcopenia. Journal of Clinical Endocrinology and Metabolism, 84, 3420-3430. (Pubitemid 30645186)
10. Brower, K. (1997). Withdrawal from anabolic steroids. Current Therapy in Endocrinology and Metabolism, 6, 338-343.
11. Brower,K. (2002).Anabolic steroid abuse and dependence. Current Psychiatry Report, 4, 377-387.
12. Daly, R., Su, T., Schmidt, P., Pickar, D., Murphy, D., & Rubinow, D. (2001). Cerebrospinal fluid and behavioral changes after methyltestosterone administration. Archives of General Psychiatry, 58(2), 172-177. (Pubitemid 32142755)
13. Drug Enforcement Administration. (2004). Steroid abuse in today's society: A guide for understanding steroids and related substances [Brochure].Washington, DC: US Department of Justice.
14. Drug Enforcement Administration. (2006a). Briefs and background, drugs and drug abuse, drug descriptions, steroids factsheet. Retrieved April 26, 2006, from http://www.dea.gov/concern/steroidsfactsheet.html
15. Drug Enforcement Administration. (2006b). Dispensing and purchasing controlled substances over the Internet: Questions and answers. Retrieved August 22, 2006, from http://www.deadiversion.usdoj.gov/faq/internetpurch.htm
16. Evans, N. (1997). Local complications of self-administered anabolic steroid injections. British Journal of Sports Medicine, 31(4), 319-321.
17. Forman, R. F. (2003). Availability of opioids on the Internet. Journal of the American Medical Association, 290(7), 887.
18. Forman, R. F. (2006). Narcotics on the Net: The availability of web sites selling controlled substances. Psychiatric Services, 57, 24-26. (Pubitemid 43053831)
19. Forman, R., Marlowe, D., & McLellan, T. (2006). The Internet as a source of drugs of abuse. Current Psychiatry Reports, 8, 377-382. (Pubitemid 44515390)
20. Forman, R. F.,Woody, G. E.,McLellan, T., & Lynch, K. G. (2006). The availability of websites offering to sell opioid medications without prescriptions. American Journal of Psychiatry, 163, 1233-1238. (Pubitemid 44464452)
21. Grinspoon, S., Corcoran, C., Parlman, K., Costello, M., Rosenthal, D., Anderson, E., et al. (2000). Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. Annals of Internal Medicine, 133(5), 348-355.
22. Grunbaum, J., Kann, L., Kinchen, S., Ross, J., Hawkins, J., Lowry, R., et al. (2004). Youth Risk Behavior Surveillance-United States 2003. MMWR: Morbidity and Mortality Weekly Report, 52(SS-2), 1-95.
23. Hartgens, F., & Kuipers, H. (2004). Effects of androgenic-anabolic steroids in athletes. Sports Medicine, 34(8), 513-554. (Pubitemid 38981844)
24. Herr, A., Rehmert, G., Kunde, K., Gust, R., & Gries, A. (2002). A thirty-year old bodybuilder with septic shock and ARDS from abuse of anabolic steroids. Anesthetist, 51(7), 557-563. (Pubitemid 34879481)
25. Hoover, V., Marlowe, D. B., Patapis, N. S., Festinger, D. S., & Forman, R. F. (2008). Internet access to Salvia divinorum: Implications for policy, prevention, and treatment. Journal of Substance Abuse Treatment, 35(1), 22-27. (Pubitemid 351734593)
26. Jarow, J., & Lipshultz, L. (1990). Anabolic steroid-induced hypogonadotrophic hypogonadism. American Journal of Sports Medicine, 18, 429-431.
27. Johnston, L. D., O'Malley, P. M., Bachman, J. G.,&Schulenberg, J. E. (2006). Monitoring the future national results on adolescent drug use: Overview of key findings, 2005 (NIH Publication No. 06-5882). Bethesda, MD: National Institute on Drug Abuse.
28. Kuhn, C. M. (2002). Anabolic steroids. Recent Progress in Hormone Research, 57, 411-434.
29. Lenhart,A., Madden, M.,&Hitlin, P. (2005). Teens and technology: Youth are leading the transition to a fully wired and mobile nation. Washington, DC: Pew Internet and American Life Project.
30. Leone, J., & Fetro, J. (2007). Perceptions and attitudes toward androgenic-anabolic steroid use among two age categories: A qualitative inquiry. Journal of Strength and Conditioning Research, 21(2), 532-537.
31. Martorana, G., Concetti, S., Manferrari, F., & Creti, S. (1999). Anabolic steroid abuse and renal cell carcinoma. Journal of Urology, 162, 2089.
32. Maycock, B., & Howat, P. (2005). The barriers to illegal anabolic steroid use. Drugs: Education, Prevention and Policy, 14(4), 317-325. (Pubitemid 40950388)
33. MedlinePlus. (2007, January 11). MedlinePlus drug information: Oxandrolone. Retrieved January 11, 2007, from http://www. nlm.nih.gov/ medlineplus/druginfo/medmaster/a604024.html
34. Nakao, A., Sakagami, K., Nakata, Y., Komazawa, K., Amimoto, T., Nakashima, K., et al. (2000).Multiple hepatic adenomas caused by long-term administration of androgenic steroids for aplastic anemia in association with familial adenomatous polyposis. Journal of Gastroenterology, 35(7), 557-562. (Pubitemid 30468464)
35. National Institute on Drug Abuse. (2000). NIDA research report series: Anabolic steroid abuse (NIH Publication No. 00-3721). Washington, DC: US Department of Health and Human Services.
36. Parssinen, M., Kujala, U., Vartiainen, E., Sarna, S., & Seppala, T. (2000). Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. International Journal of Sports Medicine, 21, 225-227. (Pubitemid 30260844)
37. Peters, R., Copeland, J., Dillon, P., & Beel, A. (1997). Patterns and correlates of anabolic-androgenic steroid use (Technical Report No. 48). Sydney: National Drug and Alcohol Research Centre.
38. Physician's Desk Reference. (2006). Oxandrin R® ; indications and usage (60th ed., p. 2977). Stamford, CT: Thompson Healthcare.
39. Pope, H., Cohane, G., Kanayama, G., Siegel, A., & Hudson, J. (2003). Testosterone gel supplementation for men with refractory depression: A randomized, placebo-controlled trial. American Journal of Psychiatry, 160(1), 105-111. (Pubitemid 36042433)
40. Pope, H., & Katz, D. (1994). Psychiatric and medical effects of anabolic-androgenic steroid use: A controlled study of 160 athletes. Archives of General Psychiatry, 51, 375-382. (Pubitemid 24176815)
41. Pope, H., Kouri, E., & Hudson, J. (2000). Effects of supraphysiological doses of testosterone on mood and aggression in normal men: A randomized controlled trial. Archives of General Psychiatry, 57, 133-140. (Pubitemid 30075263)
42. Rich, J. D., Dickinson, B. P., Feller, A., Pugatch, D., & Mylonakis, E. (1999). The infectious complications of anabolicandrogenic steroid injection. International Journal of Sports Medicine, 20(8), 563-566.
43. Schepis, T. S., Marlowe, D. B., & Forman, R. F. (2008). The availability and portrayal of stimulants over the Internet. Journal of Adolescent Health, 42(5), 458-465.
44. Sinha-Hikim, I., Artaza, J., Woodhouse, L., Gonzalez-Cadavid, N., Singh, A., Lee, M., et al. (2002). Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. American Journal of Physiology-Endocrinology and Metabolism, 283, E154-E164. (Pubitemid 34686681)
45. Strawford, A., Barbieri, T., Van Loan,M., Parks, E., Catlin, D., Barton, N., et al. (1999). Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss. Journal of the American Medical Association, 281(14), 1282-1290. (Pubitemid 29174479)
46. United States Code. (2006). (21), (13), (I), (B) U.S.C. §: 812.
47. United States Government Accountability Office. (2005). Anabolic steroids are easily purchased without a prescription and present significant challenges to law enforcement officials (GAO-06-243R). Washington, DC: Author.
48. Wichstrom, L. (2006). Predictors of future anabolic androgenic steroid use. Medicine and Science in Sports and Exercise, 38(9), 1578-1583. (Pubitemid 44373776)
49. Wight, J., & Salem, D. (1995). Sudden cardiac death and the "athlete's heart." Archives of Internal Medicine, 155, 1473-1480.
50. Yates, W. (2000). Testosterone in psychiatry: Risks and benefits. Archives of General Psychiatry, 57, 155-156. (Pubitemid 30075266)